Risk Factor Control Before Orthopedic Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 198 participants.
Also called NCT01837069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 198 participants
- Sponsor
- Registry
-
NCT01837069
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01837069. Randomized; no masking; primary purpose prevention. Start 2014-02 (registry gives no type); primary completion 2018-04-02 (actual). Results posted on 2020-07-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Risk Factor Control Before Orthopedic Surgery
- Acronym
- OPTMIZE-OS
- Condition
- Osteoarthritis
- Condition
- Cardiovascular Disease
- Intervention (Drug)
- Metoprolol
- Intervention (Drug)
- Lisinopril
- Intervention (Drug)
- Atorvastatin
- Intervention (Behavioral)
- Lifestyle counseling
- Lead sponsor
- NYU Langone Health
Record details
- Record id
cardio:ct-nct01837069- Content hash
b094ca78752badcbea9b4ae88cca40e501275d0df457287f6f6d8de22ed3c7bf